Concord Biotech announced that the European Union Good Manufacturing Practice (EU-GMP) authorities have conducted their first ...

Fundamental View According to Pal, Aurobindo is among India’s leading pharmaceutical companies with a strong presence in generic drugs, formulations, and APIs across regulated markets such as the U.S.

The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” ...

Emzor Pharmaceutical Industries Ltd (Emzor), a leading light in the Nigerian pharmaceutical sector, has announced the successful repayment of its inaugural ...

The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.

The global pharmaceutical API manufacturing market is expected to grow from $179.05 billion in 2021 to $195.29 billion in 2022 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine ...

The global Active Pharmaceutical Ingredients (API) Market is valued at USD 155.2 Billion in 2023 and is projected to reach a value of USD 314.24 Billion by 2032 at a CAGR (Compound Annual Growth Rate) ...

As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars ...

US pharma major AbbVie yesterday announced a $195 million investment in its North Chicago, Illinois manufacturing plant to ...